SMT201400176B - [Etil(dimetil)ammonio]butanoato nel trattamento diuna malattia cardiovascolare - Google Patents

[Etil(dimetil)ammonio]butanoato nel trattamento diuna malattia cardiovascolare

Info

Publication number
SMT201400176B
SMT201400176B SM201400176T SM201400176T SMT201400176B SM T201400176 B SMT201400176 B SM T201400176B SM 201400176 T SM201400176 T SM 201400176T SM 201400176 T SM201400176 T SM 201400176T SM T201400176 B SMT201400176 B SM T201400176B
Authority
SM
San Marino
Prior art keywords
butanoate
dimethyl
ammonium
ethyl
treatment
Prior art date
Application number
SM201400176T
Other languages
English (en)
Italian (it)
Inventor
Ivars Kalvins
Maija Dambrova
Edgars Liepins
Osvalds Pugovics
Reinis Vilskersts
Janis Kuka
Solveiga Grinberga
Einars Loza
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of SMT201400176B publication Critical patent/SMT201400176B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201400176T 2009-10-22 2014-11-21 [Etil(dimetil)ammonio]butanoato nel trattamento diuna malattia cardiovascolare SMT201400176B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-09-181A LV14345B (lv) 2009-10-22 2009-10-22 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
PCT/EP2010/065924 WO2011048201A1 (en) 2009-10-22 2010-10-22 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

Publications (1)

Publication Number Publication Date
SMT201400176B true SMT201400176B (it) 2015-01-15

Family

ID=43530044

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400176T SMT201400176B (it) 2009-10-22 2014-11-21 [Etil(dimetil)ammonio]butanoato nel trattamento diuna malattia cardiovascolare

Country Status (33)

Country Link
US (2) US9278907B2 (sl)
EP (1) EP2491005B1 (sl)
JP (1) JP5552169B2 (sl)
KR (1) KR101355417B1 (sl)
CN (1) CN102666476B (sl)
AR (1) AR081514A1 (sl)
AU (1) AU2010309756B2 (sl)
BR (1) BR112012009162B8 (sl)
CA (1) CA2781499C (sl)
CL (1) CL2012001010A1 (sl)
CO (1) CO6531459A2 (sl)
CU (1) CU20120065A7 (sl)
DK (1) DK2491005T3 (sl)
EA (1) EA020303B1 (sl)
ES (1) ES2508117T3 (sl)
GE (1) GEP20146123B (sl)
HK (1) HK1169824A1 (sl)
HR (1) HRP20140964T1 (sl)
IL (1) IL219217A0 (sl)
LV (1) LV14345B (sl)
ME (1) ME01917B (sl)
MX (1) MX2012004630A (sl)
NZ (1) NZ599521A (sl)
PE (1) PE20121473A1 (sl)
PL (1) PL2491005T3 (sl)
PT (1) PT2491005E (sl)
RS (1) RS53620B1 (sl)
SI (1) SI2491005T1 (sl)
SM (1) SMT201400176B (sl)
TN (1) TN2012000174A1 (sl)
UA (1) UA107201C2 (sl)
WO (1) WO2011048201A1 (sl)
ZA (1) ZA201202916B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8565150B2 (en) * 2009-03-11 2013-10-22 At&T Mobility Ii Llc Architectural model for LTE (long term evolution) EPC (evolved packet core) deployment
RS55092B1 (sr) * 2011-04-27 2016-12-30 Grindeks Jsc Upotreba 3-karboksi-n-etil-n,n-dimetilpropan-1-aminijum soli u lečenju kardiovaskularne bolesti
DE102012109911A1 (de) 2011-10-19 2013-04-25 Electronics And Telecommunications Research Institute Energy harvesting device using electromagnetic interference signal and sensor system including the same
JO3117B1 (ar) * 2012-12-20 2017-09-20 Grindeks Jsc استعمال 3- كربوكسي- ن-إيثيل- ن، ن- ثاني ميثيل بروبان-1– أمينيوم أو ملح منه مقبول صيدلانياً في معالجة تصلب الشرايين
JO3333B1 (ar) * 2013-09-26 2019-03-13 Grindeks Jsc استعمال 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium أو ملح مقبول دوائيا منه للوقاية من السكري وعلاجه
CN107879944B (zh) * 2017-10-30 2020-05-22 杭州海尔希畜牧科技有限公司 一种制备丁基甜菜碱的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238868A (sl) 1967-08-08 1971-07-14
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
IT1210935B (it) 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US4933103A (en) * 1987-03-23 1990-06-12 Kao Corporation Bleaching composition
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
JPH0291049A (ja) * 1988-09-21 1990-03-30 Lonza Ag r―ブチロベタインの製造方法
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11728B (en) 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
US5973026A (en) 1998-02-02 1999-10-26 Xerox Corporation Ink jet inks
JP2000239239A (ja) * 1999-02-22 2000-09-05 Kankyo Meneki Gijutsu Kenkyusho:Kk クロルメコート類縁化合物のハプテン化合物、抗体及び測定方法
CA2508094A1 (en) 2005-05-20 2006-11-20 Vivier Canada Inc. Composition for accelerating collagen synthesis
US7863274B2 (en) 2005-07-29 2011-01-04 Concert Pharmaceuticals Inc. Deuterium enriched analogues of tadalafil as PDE5 inhibitors
LV13705B (en) 2006-11-06 2008-07-20 Ivars Kalvins Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide
JP4761265B2 (ja) 2007-10-17 2011-08-31 学校法人甲南学園 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法
CN101538214A (zh) * 2009-04-24 2009-09-23 潍坊祥维斯化学品有限公司 生产γ-丁基甜菜碱及其盐酸盐的方法
WO2012146737A1 (en) * 2011-04-27 2012-11-01 Grindeks, A Joint Stock Company 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease

Also Published As

Publication number Publication date
UA107201C2 (uk) 2014-12-10
ME01917B (me) 2015-05-20
ES2508117T3 (es) 2014-10-16
NZ599521A (en) 2013-11-29
BR112012009162A2 (pt) 2020-08-18
EA020303B1 (ru) 2014-10-30
CU24114B1 (sl) 2015-08-27
PL2491005T3 (pl) 2015-03-31
AU2010309756A1 (en) 2012-05-17
MX2012004630A (es) 2013-07-29
CU20120065A7 (es) 2012-06-29
HK1169824A1 (en) 2013-02-08
CA2781499A1 (en) 2011-04-28
CO6531459A2 (es) 2012-09-28
US20120220656A1 (en) 2012-08-30
SI2491005T1 (sl) 2014-12-31
BR112012009162B8 (pt) 2021-07-27
KR20120101634A (ko) 2012-09-14
JP2013508342A (ja) 2013-03-07
CN102666476B (zh) 2014-07-09
EP2491005B1 (en) 2014-07-23
PE20121473A1 (es) 2012-11-18
CA2781499C (en) 2015-03-24
CL2012001010A1 (es) 2012-08-31
WO2011048201A1 (en) 2011-04-28
EA201200514A1 (ru) 2012-09-28
LV14345A (lv) 2011-05-20
IL219217A0 (en) 2012-06-28
KR101355417B1 (ko) 2014-01-27
US9278907B2 (en) 2016-03-08
AU2010309756B2 (en) 2013-10-17
JP5552169B2 (ja) 2014-07-16
LV14345B (lv) 2011-07-20
GEP20146123B (en) 2014-07-25
TN2012000174A1 (en) 2013-12-12
EP2491005A1 (en) 2012-08-29
US9573882B2 (en) 2017-02-21
BR112012009162B1 (pt) 2021-02-02
AR081514A1 (es) 2012-10-03
RS53620B1 (en) 2015-04-30
US20160137589A1 (en) 2016-05-19
PT2491005E (pt) 2014-10-29
HRP20140964T1 (hr) 2014-12-05
ZA201202916B (en) 2013-05-29
CN102666476A (zh) 2012-09-12
DK2491005T3 (da) 2014-10-27

Similar Documents

Publication Publication Date Title
SMT201400176B (it) [Etil(dimetil)ammonio]butanoato nel trattamento diuna malattia cardiovascolare
SMT201400100B (it) Processo migliorato
FR2963449B1 (fr) Conversion d'un bus bifilaire en bus unifilaire
BRPI0910820A2 (pt) processo de preparação de sílica precipitada, sílica precipitada, e, utilização de uma sílica
DK2361256T3 (da) Cyclohexenyl-nukleinsyreanaloger
BRPI0915487A2 (pt) hemaglutina de nfluenza e variantes de neuraminidase
BRPI0917575A2 (pt) métodos de tratamento de talassemia
BRPI0821944A2 (pt) Processo
BR112012000821A2 (pt) "processo"
BRPI0919868A2 (pt) processo
BR112012000822A2 (pt) processo
SMT201300007B (it) Trattamento di una malattia respiratoria
BR112012012338A2 (pt) processo
BRPI0921374A2 (pt) processo
FI20095433A0 (fi) Mikroneula
EP2267151A4 (en) METHOD FOR TITRATION OF VIRUSES
ZA201107716B (en) Combined vaporising/stripping absorption module
BRPI0910534A2 (pt) terapia antiviral
BRPI1007573A2 (pt) processo
BRPI0922972A2 (pt) Processo de preparo de ésteres ativados.
BR112013000225A2 (pt) ''processo''
BR112012003642A2 (pt) processo
SMT201500159B (it) Struttura gradini
BRPI1007151A2 (pt) processo, e, uso de um composto
BRPI1011571A2 (pt) Processo